{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:44:05Z","timestamp":1777581845215,"version":"3.51.4"},"reference-count":36,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2021,1,17]],"date-time":"2021-01-17T00:00:00Z","timestamp":1610841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Due to globally rising numbers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, resources for real-time reverse-transcription polymerase chain reaction (rRT-PCR)-based testing have been exhausted. In order to meet the demands of testing and reduce transmission, SARS-CoV-2 antigen-detecting rapid diagnostic tests (Ag-RDTs) are being considered. These tests are fast, inexpensive, and simple to use, but whether they detect potentially infectious cases has not been well studied. We evaluated three lateral flow assays (RIDA\u00aeQUICK SARS-CoV-2 Antigen (R-Biopharm), SARS-CoV-2 Rapid Antigen Test (Roche)), and NADAL\u00ae COVID-19 Ag Test (Nal von Minden GmbH, Regensburg, Germany) and one microfluidic immunofluorescence assay (SARS-CoV-2 Ag Test (LumiraDx GmbH, Cologne, Germany)) using 100 clinical samples. Diagnostic rRT-PCR and cell culture testing as a marker for infectivity were performed in parallel. The overall Ag-RDT sensitivity for rRT-PCR-positive samples ranged from 24.3% to 50%. However, for samples with a viral load of more than 6 log10 RNA copies\/mL (22\/100), typically seen in infectious individuals, Ag-RDT positivity was between 81.8% and 100%. Only 51.6% (33\/64) of the rRT-PCR-positive samples were infectious in cell culture. In contrast, three Ag-RDTs demonstrated a more significant correlation with cell culture infectivity (61.8\u201382.4%). Our findings suggest that large-scale SARS-CoV-2 Ag-RDT-based testing can be considered for detecting potentially infective individuals and reducing the virus spread.<\/jats:p>","DOI":"10.3390\/jcm10020328","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T05:17:34Z","timestamp":1610947054000},"page":"328","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":150,"title":["The Comparative Clinical Performance of Four SARS-CoV-2 Rapid Antigen Tests and Their Correlation to Infectivity In Vitro"],"prefix":"10.3390","volume":"10","author":[{"given":"Niko","family":"Kohmer","sequence":"first","affiliation":[{"name":"Institute for Medical Virology, University Hospital, Goethe University Frankfurt, 60596 Frankfurt, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5399-9263","authenticated-orcid":false,"given":"Tuna","family":"Toptan","sequence":"additional","affiliation":[{"name":"Institute for Medical Virology, University Hospital, Goethe University Frankfurt, 60596 Frankfurt, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiane","family":"Pallas","sequence":"additional","affiliation":[{"name":"Institute for Medical Virology, University Hospital, Goethe University Frankfurt, 60596 Frankfurt, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onur","family":"Karaca","sequence":"additional","affiliation":[{"name":"Institute for Medical Virology, University Hospital, Goethe University Frankfurt, 60596 Frankfurt, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7387-1497","authenticated-orcid":false,"given":"Annika","family":"Pfeiffer","sequence":"additional","affiliation":[{"name":"Institute for Medical Virology, University Hospital, Goethe University Frankfurt, 60596 Frankfurt, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Westhaus","sequence":"additional","affiliation":[{"name":"Institute for Medical Virology, University Hospital, Goethe University Frankfurt, 60596 Frankfurt, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5417-9307","authenticated-orcid":false,"given":"Marek","family":"Widera","sequence":"additional","affiliation":[{"name":"Institute for Medical Virology, University Hospital, Goethe University Frankfurt, 60596 Frankfurt, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annemarie","family":"Berger","sequence":"additional","affiliation":[{"name":"Institute for Medical Virology, University Hospital, Goethe University Frankfurt, 60596 Frankfurt, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5100-9385","authenticated-orcid":false,"given":"Sebastian","family":"Hoehl","sequence":"additional","affiliation":[{"name":"Institute for Medical Virology, University Hospital, Goethe University Frankfurt, 60596 Frankfurt, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Kammel","sequence":"additional","affiliation":[{"name":"Institut fuer Qualitaetssicherung in der Virusdiagnostik-IQVD der GmbH, 14129 Berlin, Germany"},{"name":"INSTAND Gesellschaft zur Foerderung der Qualitaetssicherung in Medizinischen Laboratorien e.V., 40223 Duesseldorf, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1802-7565","authenticated-orcid":false,"given":"Sandra","family":"Ciesek","sequence":"additional","affiliation":[{"name":"Institute for Medical Virology, University Hospital, Goethe University Frankfurt, 60596 Frankfurt, Germany"},{"name":"German Centre for Infection Research, External Partner Site, 60323 Frankfurt, Germany"},{"name":"Fraunhofer Institute for Molecular Biology and Applied Ecology (IME), Branch Translational Medicine and Pharmacology, 60596 Frankfurt, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger F.","family":"Rabenau","sequence":"additional","affiliation":[{"name":"Institute for Medical Virology, University Hospital, Goethe University Frankfurt, 60596 Frankfurt, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,1,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jiph.2020.06.005","article-title":"Laboratory diagnosis of SARS-CoV-2\u2014A review of current methods","volume":"13","author":"Mathuria","year":"2020","journal-title":"J. Infect. Public Health"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1080\/22221751.2020.1745095","article-title":"Laboratory diagnosis of emerging human coronavirus infections\u2014The state of the art","volume":"9","author":"Loeffelholz","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"ref_3","unstructured":"WHO (2020, December 14). WHO Coronavirus Disease (COVID-19) Dashboard. Available online: https:\/\/covid19.who.int\/."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Manabe, Y.C., Sharfstein, J.S., and Armstrong, K. (2020). The Need for More and Better Testing for COVID-19. JAMA.","DOI":"10.1001\/jama.2020.21694"},{"key":"ref_5","unstructured":"FIND (2020, December 21). SARS-CoV-2 Diagnostic Pipeline. Available online: https:\/\/www.finddx.org\/covid-19\/pipeline\/?avance=Commercialized&type=Rapid+diagnostic+tests&test_target=Antigen&status=all&section=immunoassays&action=default#diag_tab."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"104659","DOI":"10.1016\/j.jcv.2020.104659","article-title":"Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms","volume":"133","author":"Linares","year":"2020","journal-title":"J. Clin. Virol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Nalumansi, A., Lutalo, T., Kayiwa, J., Watera, C., Balinandi, S., Kiconco, J., Nakaseegu, J., Olara, D., Odwilo, E., and Serwanga, J. (2020). Field Evaluation of the Performance of a SARS-CoV-2 Antigen Rapid Diagnostic Test in Uganda using Nasopharyngeal Samples. Int. J. Infect. Dis.","DOI":"10.1016\/j.ijid.2020.10.073"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Mak, G.C.K., Lau, S.S.Y., Wong, K.K.Y., Chow, N.L.S., Lau, C.S., Lam, E.T.K., Chan, R.C.W., and Tsang, D.N.C. (2020). Analytical sensitivity and clinical sensitivity of the three rapid antigen detection kits for detection of SARS-CoV-2 virus. J. Clin. Virol., 104684.","DOI":"10.1016\/j.jcv.2020.104684"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"104654","DOI":"10.1016\/j.jcv.2020.104654","article-title":"Urgent need of rapid tests for SARS CoV-2 antigen detection: Evaluation of the SD-Biosensor antigen test for SARS-CoV-2","volume":"132","author":"Cerutti","year":"2020","journal-title":"J. Clin. Virol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"104455","DOI":"10.1016\/j.jcv.2020.104455","article-title":"Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis","volume":"129","author":"Scohy","year":"2020","journal-title":"J. Clin. Virol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Lambert-Niclot, S., Cuffel, A., Le Pape, S., Vauloup-Fellous, C., Morand-Joubert, L., Roque-Afonso, A.-M., Le Goff, J., and Delaugerre, C. (2020). Evaluation of a Rapid Diagnostic Assay for Detection of SARS-CoV-2 Antigen in Nasopharyngeal Swabs. J. Clin. Microbiol., 58.","DOI":"10.1128\/JCM.00977-20"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3389\/fmed.2020.00225","article-title":"Development and Potential Usefulness of the COVID-19 Ag Respi-Strip Diagnostic Assay in a Pandemic Context","volume":"7","author":"Mertens","year":"2020","journal-title":"Front. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ijid.2020.05.098","article-title":"Evaluation of a novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples","volume":"99","author":"Porte","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Toptan, T., Eckermann, L., Pfeiffer, A.E., Hoehl, S., Ciesek, S., Drosten, C., and Corman, V.M. (2020). Evaluation of a SARS-CoV-2 rapid antigen test: Potential to help reduce community spread?. J. Clin. Virol., 104713.","DOI":"10.1101\/2020.12.04.20240283"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","article-title":"Virological assessment of hospitalized patients with COVID-2019","volume":"581","author":"Corman","year":"2020","journal-title":"Nature"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Albert, E., Torres, I., Bueno, F., Huntley, D., Molla, E., Fern\u00e1ndez-Fuentes, M.\u00c1., Mart\u00ednez, M., Poujois, S., Forqu\u00e9, L., and Valdivia, A. (2020). Field evaluation of a rapid antigen test (Panbio\u2122 COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres. Clin. Microbiol. Infect.","DOI":"10.1101\/2020.10.16.20213850"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Basile, K., McPhie, K., Carter, I., Alderson, S., Rahman, H., Donovan, L., Kumar, S., Tran, T., Ko, D., and Sivaruban, T. (2020). Cell-based culture of SARS-CoV-2 informs infectivity and safe de-isolation assessments during COVID-19. Clin Infect Dis.","DOI":"10.1101\/2020.07.14.20153981"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Toptan, T., Hoehl, S., Westhaus, S., Bojkova, D., Berger, A., Rotter, B., Hoffmeier, K., Cinatl, J., Ciesek, S., and Widera, M. (2020). Optimized qRT-PCR Approach for the Detection of Intra- and Extra-Cellular SARS-CoV-2 RNAs. Int. J. Mol. Sci., 21.","DOI":"10.1101\/2020.04.20.052258"},{"key":"ref_19","unstructured":"WHO (2020, December 21). Molecular Assays to Diagnose COVID-19: Summary Table of Available Protocols. Available online: https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/whoinhouseassays.pdf?sfvrsn=de3a76aa_2."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Westhaus, S., Widera, M., Rabenau, H.F., Hoehl, S., Bojkova, D., Cinatl, J., and Ciesek, S. (2020). Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings. bioRxiv.","DOI":"10.1101\/2020.09.11.292581"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1037\/h0026256","article-title":"Weighted kappa: Nominal scale agreement with provision for scaled disagreement or partial credit","volume":"70","author":"Cohen","year":"1968","journal-title":"Psychol. Bull."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Corman, V.M., Haage, V.C., Bleicker, T., Schmidt, M.L., M\u00fchlemann, B., Zuchowski, M., J\u00f3 Lei, W.K., Tscheak, P., M\u00f6ncke-Buchner, E., and M\u00fcller, M.A. (2020). Comparison of seven commercial SARS-CoV-2 rapid Point-of-Care Antigen tests. medRxiv.","DOI":"10.1101\/2020.11.12.20230292"},{"key":"ref_24","unstructured":"WHO (2020, December 21). Antigen-Detection in the Diagnosis of SARS-CoV-2 Infection Using Rapid Immunoassays: Interim Guidance. Available online: https:\/\/www.who.int\/publications\/i\/item\/antigen-detection-in-the-diagnosis-of-sars-cov-2infection-using-rapid-immunoassays."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.3201\/eid2611.203219","article-title":"SARS-CoV-2 Virus Culture and Subgenomic RNA for Respiratory Specimens from Patients with Mild Coronavirus Disease","volume":"26","author":"Perera","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"ref_26","unstructured":"WHO (2020, December 21). COVID-19 Target Product Profiles for Priority Diagnostics to Support Response to the COVID-19 Pandemic v.1.0. Available online: https:\/\/www.who.int\/publications\/m\/item\/covid-19-target-product-profiles-for-priority-diagnostics-to-support-response-to-the-covid-19-pandemic-v.0.1."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s10096-020-03913-9","article-title":"Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards","volume":"39","author":"Andreani","year":"2020","journal-title":"Eur J. Clin. Microbiol Infect. Dis"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Van Kampen, J.J., van de Vijver, D.A., Fraaij, P.L., Haagmans, B.L., Lamers, M.M., Okba, N., van den Akker, J.P., Endeman, H., Gommers, D.A., and Cornelissen, J.J. (2020). Shedding of infectious virus in hospitalized patients with coronavirus disease-2019 (COVID-19): Duration and key determinants. medRxiv.","DOI":"10.1101\/2020.06.08.20125310"},{"key":"ref_29","unstructured":"WHO (2021, January 08). Criteria for Releasing COVID-19 Patients from Isolation. Available online: https:\/\/www.who.int\/publications\/i\/item\/criteria-for-releasing-covid-19-patients-from-isolation."},{"key":"ref_30","unstructured":"CDC (2021, January 08). Duration of Isolation and Precautions for Adults with COVID-19, Available online: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/duration-isolation.html."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Pekosz, A., Cooper, C.K., Parvu, V., Li, M., Andrews, J.C., Manabe, Y.C., Kodsi, S., Leitch, J., Gary, D.S., and Roger-Dalbert, C. (2020). Antigen-based testing but not real-time PCR correlates with SARS-CoV-2 virus culture. medRxiv.","DOI":"10.1101\/2020.10.02.20205708"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41586-020-2342-5","article-title":"Pathogenesis and transmission of SARS-CoV-2 in golden hamsters","volume":"583","author":"Sia","year":"2020","journal-title":"Nature"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Hoehl, S., Schenk, B., Rudych, O., G\u00f6ttig, S., Foppa, I., Kohmer, N., Karaca, O., Toptan, T., and Ciesek, S. (2020). At-home self-testing of teachers with a SARS-CoV-2 rapid antigen test to reduce potential transmissions in schools. medRxiv.","DOI":"10.1101\/2020.12.04.20243410"},{"key":"ref_34","unstructured":"ECDC (2021, January 08). Options for the Use of Rapid Antigen Tests for COVID-19in the EU\/EEA and the UK. Available online: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/Options-use-of-rapid-antigen-tests-for-COVID-19.pdf."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Larremore, D.B., Wilder, B., Lester, E., Shehata, S., Burke, J.M., Hay, J.A., Tambe, M., Mina, M.J., and Parker, R. (2020). Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening. Sci. Adv.","DOI":"10.1101\/2020.06.22.20136309"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Mina, M.J., Parker, R., and Larremore, D.B. (2020). Rethinking Covid-19 Test Sensitivity\u2014A Strategy for Containment. N. Engl. J. Med.","DOI":"10.1056\/NEJMp2025631"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/2\/328\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:12:12Z","timestamp":1760159532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/2\/328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,17]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,1]]}},"alternative-id":["jcm10020328"],"URL":"https:\/\/doi.org\/10.3390\/jcm10020328","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,17]]}}}